Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2014 Aug;18(8):587-90.
doi: 10.1089/gtmb.2014.0061. Epub 2014 Jun 23.

Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a population genetics perspective

Aysegul Bayramoglu  1 , Hasan Veysi Gunes, Muzaffer Metintas, Irfan Degirmenci, Halil Ibrahim Guler, Cengiz Ustuner, Ahmet Musmul
Affiliations
Clinical Trial

Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a population genetics perspective

Aysegul Bayramoglu et al. Genet Test Mol Biomarkers. 2014 Aug.

Abstract

Aim: The aim of this study was to investigate the polymorphism frequency of plasminogen activator inhibitor-1 (PAI-1) (rs1799889) 4G/5G in patients with lung cancer.

Methods: In this study, 286 genomic DNAs (154 lung cancer patients+132 subjects without lung cancer) were analyzed. Polymorphisms were determined by using the polymerase chain reaction (PCR) method, with 4G and 5G allele-specific primers. PCR products were assessed by a charge-coupled device camera and exposed to 2% agarose gel electrophoresis.

Results: The frequencies of the PAI-1 gene 4G/5G genotypes were found to be 21% 4G/4G, 16% 4G/5G, and 62% 5G/5G in the control group and 31.4% 4G/4G, 30.8% 4G/5G, and 37.8% 5G/5G in the patient group. It was determined that the 5G/5G genotype frequency was high in patients in comparison with other genotypes.

Conclusions: This study found a statistically significant difference between the groups with respect to genotype distribution. Consequently, we can say that the PAI-1 gene 4G/5G polymorphism is associated with lung cancer in Turkey.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Ak G, Metintas M, Metintas S, et al. (2006) Epidemiologic, clinical and radiological features affecting stages at diagnosis of patients with lung cancer. Osmangazi Med J 28:17–31
    1. Akhter MS, Biswas A, Ranjan R, et al. (2010) Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis. Clin Appl Thromb Hemost 16:184–188 - PubMed
    1. Augustine A, Harris RE, Wynder EL. (1989) Compensation as a risk factor for lung cancer in smokers who switch from nonfilterto filter cigarettes. Am J Public Health 79:188–191 - PMC - PubMed
    1. Bayramoglu A, Gunes HV, Metintas M, et al. (2009) The association of MMP-9 enzyme activity, MMP-9 C1562T polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 gene expression in lung cancer. Genet Test Mol Biomark 13:671–678 - PubMed
    1. Bayramoglu A, Gunes HV, Metintas M, et al. (2011) Is a single nucleotide polymorphism a risk factor for lung cancer in the matrix metalloproteinase-2 promoter? Mol Biol Rep 38:1469–1474 - PubMed

Publication types

Substances

LinkOut - more resources